Advances in the diagnosis and treatment of HBeAg-negative chronic hepatitis B / 临床肝胆病杂志

ABSTRACT

Chronic hepatitis B (CHB) is one of the most common chronic infectious diseases in China, and the prevalence rate of HBeAg-negative CHB has been increasing year by year, causing serious harm to the security of public health in China. With reference to the pathogenesis, diagnosis, and treatment of HBeAg-negative CHB, this article reviews the clinical research advances in recent years and summarizes the new advances in the diagnosis and treatment of HBeAg-negative CHB.